Health
Scientists identify key molecules that mediate radioresistance in aggressive brain cancer – News-Medical.Net
Scientists have identified key molecules that mediate radioresistance in glioblastoma multiforme; these molecules are a potential target for the treatment of th…
Reviewed by Emily Henderson, B.Sc.Sep 30 2020
Scientists have identified key molecules that mediate radioresistance in glioblastoma multiforme; these molecules are a potential target for the treatment of this brain cancer.
Glioblastoma multiforme (GBM), is the most aggressive type of brain cancer. It is treated by radiation therapy combined with chemotherapy. However, even with treatment, the five-year survival rate for GBM is less than 7%. One of the major causes for this is that GBM rapidly …
-
Business12 hours agoRanking the best “Magnificent Seven” stocks to buy for 2026. Here’s my No. 5 pick.
-
General14 hours agoSex work influencers call out lack of transparency as young girls targeted by viral social media content
-
Business14 hours agoWhere to invest $10,000 in ASX ETFs this December
-
General9 hours agoFormer truck driver’s garage memorabilia collection sold to Westonia to drive tourism